Status:
RECRUITING
Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
Lead Sponsor:
Huashan Hospital
Conditions:
Respiratory Infectious Diseases
Artificial Intelligence
Eligibility:
All Genders
1-90 years
Phase:
NA
Brief Summary
The early identification and severe warning of acute respiratory infectious diseases are of paramount importance. Utilizing effective means to make correct diagnoses of the source of infection at an e...
Eligibility Criteria
Inclusion
- 1-90 years old, gender not specified.
- Exhibits symptoms of respiratory tract infection
- Must have etiological examination results
- Must have imaging data;
Exclusion
- Severe artifacts in medical images
- Clinical diagnosis indicates concurrent pulmonary edema
- Dual review results in unclear diagnosis or potential misdiagnosis
- Other situations that may cause difficulties in reading the films, or as determined by the researcher, the study participant is deemed unsuitable for enrollment.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06553911
Start Date
April 1 2022
End Date
December 1 2026
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huashan Hospital
Shanghai, China, 200040